NEU 0.85% $15.14 neuren pharmaceuticals limited

Share Price, page-6468

  1. 5,797 Posts.
    lightbulb Created with Sketch. 736
    Yes TL and validation keeps rolling in.
    What's good to read is that not only are improvements being seen, but with time those who are experiencing side affects are finding ways to deal with them eventually. Rvajna wouldn't even be aware of what daybue does and how it affects peoples lives

    My 5-year-old daughter had some serious problems with reflux and vomiting the first couple months on Daybue, but I think we have finally found a combo that is really working to solve the issue. We have her on cyproheptadine, omeprazole, and Mylanta. We tried out the Mylanta last and it seemed to be the final piece of the puzzle. Just thought I'd share for anyone else struggline with these side effects. Also, Daybue is helping her quite a lot since she started it in June. She
    is saying a few words again, walking better, has more energy, has rolled over and sat up, and her hand function is a smidge better. We're glad we pushed through those few terrible months. Good luck to everyone!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.